[Growth inhibiting therapy in osteochondrosis tibiae - Blount disease].
Therapy with estrogens was inaugurated in a girl with osteochondrosis tibiae in order to accelerate the fusion of epiphyseal lines. This therapy can be regarded as additional therapy but orthopedic therapy is necessary once growth of the patient has stopped.
D001846:Bone Development / Q000187:drug effects; D002648:Child; D004966:Estrogens, Conjugated (USP) / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D010007:Osteochondritis / Q000188:drug therapy*; D013977:Tibia / Q000187:drug effects / Q000254:growth & development
D004966:Estrogens, Conjugated (USP)
Wachstumshemmende Therapie bei der Osteochondrosis tibiae - Morbus Blount.